TREATMENT Mid-Term Review
TREATMENT School 2: The epidemic of fatty liver diseases: risk factors, treatment and extrahepatic consequences

20th November, 2018
Session I: TREATMENT Mid-Term Review (Part I)
9:00-9:15 Short introduction by the REA Project Officer, the External expert and
Project Coordinators
9:15-10:00 Tour table All scientist-in-charge should briefly present their research team and describe their role within the network.
Early Stage Researchers (ESRs) Scientific Presentations
10:00-10:25 Sangeetha Bupalan (ESR15). “Examination of endoplasmic reticulum stress markers in liver from mice treated with antipsychotic drugs” CSD, Galway.
10:25-10:50 Raphael Sirtoli (ESR14). “Schizophrenia: linking neuronal and glial structure to brain redox states” BnML, Braga
10:50-11:15 Mónica Ruíz (ESR13). “Characterization of genomic patterns that predict long-term metabolic side effects of antipsychotic treatments” NIMGenetics, Madrid
11:15-11:40 Dora Koller (ESR12). “Development and validation of a LC-MS/MS method for simultaneous determination of six atypical antipsychotics in plasma” Hospital de la Princesa, Madrid
11:40-12:05 Barbara Kramar (ESR11). “Modulation of liver cell stress responses by Ari and Ola” Uni Ljubljanaa, Ljubljana
12:05-12:15 Break and change of session room
12.15 -12:40 Priya Dipta (ESR10). “Modulation of macrophages derived cytokines and N-linked glycosylation by anti-schizophrenic drugs” HUJI, Jerusalem
12:40- 13:05 Francesca Forno (ESR9). “Cellular responses of hepatocytes to anti-schizophrenic drugs linked to obesity” HUJI, Jerusalem
13:05-13:30 Giada Di Nunzio (ESR8). “Olanzapine impact on mitochondrial bioenergetics after chronic and acute treatments in rats” CNC, Coimbra
13:30-14:30 Light lunch (Sanwichess and coffee)
14:30-14:55 Raphael Santamaría (ESR7). “Lipid flux in rats after 42 days of olanzapine treatment” CNC, Coimbra
14:55-15:20 Assel Sarsenbayeva (ESR6). “ The effect of Olanzapine and Aripiprazole on human adipose tissue metabolism” UU, Uppsala
15:20- 15:55 Catia Marilia Marques (ESR5). UU, Uppsala
15:55-16:20 Gaurang Patel (ESR4). “Role of antipsychotic drug induced mitochondrial dysfunction in the increased cardiovascular risk” IIBM, CSIC-UAM, Madrid.
16:20-16:30 Break
16:30-16:55 Ramazan Yildiz (ESR3). “Identification of the mechanisms that link liver xenobiotic catabolism” IIBM, CSIC-UAM, Madrid
16:55-17:20 Diana Grajales (ESR2). “Evaluation of antipsychotic-induced metabolic dysfunction on the endocrine pancreas” IIBM, CSIC-UAM, Madrid.
17:20- 17:55 Vitor Ferreira (ESR1). “The impact of second generation antipsychotic drugs in insulin sensitivity and glucose homeostasis” IIBM, CSIC-UAM, Madrid.
18:00-18:15 Transfer Board Meeting of ITN-TREATMENT
18:15-18:45 Executive Committees Meeting of ITN-TREATMENT
18:45-19:15 Supervisory Board Meeting of ITN-TREATMENT